Two Sigma Securities’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-16,200
| Closed | -$430K | – | 2022 |
|
|
2024
Q4 | $430K | Sell |
16,200
-624,100
| -97% | -$16.9M | 0.06% | 439 |
|
|
2024
Q3 | $18.5M | Buy |
640,300
+229,800
| +56% | +$6.7M | 0.31% | 63 |
|
|
2024
Q2 | $11.5M | Sell |
410,500
-345,900
| -46% | -$9.52M | 0.14% | 177 |
|
|
2024
Q1 | $21M | Buy |
756,400
+661,800
| +700% | +$18.4M | 0.2% | 114 |
|
|
2023
Q4 | $2.72M | Sell |
94,600
-73,400
| -44% | -$2.22M | 0.03% | 573 |
|
|
2023
Q3 | $5.57M | Sell |
168,000
-17,300
| -9% | -$612K | 0.06% | 333 |
|
|
2023
Q2 | $6.8M | Sell |
185,300
-153,600
| -45% | -$5.98M | 0.1% | 216 |
|
|
2023
Q1 | $13.8M | Buy |
338,900
+265,700
| +363% | +$11.5M | 0.28% | 62 |
|
|
2022
Q4 | $3.75M | Sell |
73,200
-331,900
| -82% | -$15.9M | 0.11% | 219 |
|
|
2022
Q3 | $17.7M | Buy |
405,100
+120,300
| +42% | +$5.85M | 0.54% | 19 |
|
|
2022
Q2 | $14.9M | Buy |
284,800
+59,700
| +27% | +$3.04M | 0.53% | 29 |
|
|
2022
Q1 | $11.7M | Buy |
225,100
+185,600
| +470% | +$9.63M | 0.41% | 28 |
|
|
2021
Q4 | $2.33M | Sell |
39,500
-67,500
| -63% | -$3.34M | 0.1% | 105 |
|
|
2021
Q3 | $4.6M | Buy |
107,000
+16,100
| +18% | +$713K | 0.13% | 124 |
|
|
2021
Q2 | $3.56M | Buy |
90,900
+71,100
| +359% | +$2.76M | 0.11% | 131 |
|
|
2021
Q1 | $717K | Sell |
19,800
-224,700
| -92% | -$7.98M | 0.04% | 218 |
|
|
2020
Q4 | $9M | Buy |
244,500
+172,406
| +239% | +$6.32M | 0.21% | 58 |
|
|
2020
Q3 | $2.51M | Buy |
72,094
+59,551
| +475% | +$2.09M | 0.05% | 172 |
|
|
2020
Q2 | $389K | Sell |
12,543
-102,975
| -89% | -$3.5M | 0.01% | 743 |
|
|
2020
Q1 | $3.58M | Sell |
115,518
-452,904
| -80% | -$15.4M | 0.08% | 153 |
|
|
2019
Q4 | $21.1M | Sell |
568,422
-177,705
| -24% | -$6.33M | 0.14% | 92 |
|
|
2019
Q3 | $25.4M | Buy |
746,127
+34,993
| +5% | +$1.27M | 0.23% | 47 |
|
|
2019
Q2 | $29.2M | Buy |
711,134
+248,428
| +54% | +$9.86M | 0.31% | 40 |
|
|
2019
Q1 | $18.6M | Buy |
462,706
+284,264
| +159% | +$11.4M | 0.17% | 57 |
|
|
2018
Q4 | $7.39M | Sell |
178,442
-459,544
| -72% | -$19.1M | 0.09% | 114 |
|
|
2018
Q3 | $26.7M | Sell |
637,986
-656,537
| -51% | -$25.3M | 0.17% | 69 |
|
|
2018
Q2 | $44.6M | Buy |
1,294,523
+81,580
| +7% | +$2.79M | 0.22% | 51 |
|
|
2018
Q1 | $40.8M | Buy |
1,212,943
+995,187
| +457% | +$34.2M | 0.23% | 64 |
|
|
2017
Q4 | $7.48M | Buy |
+217,756
| New | +$7.43M | 0.2% | 78 |
|
Other funds holding PFE
VCM
VPM
Two Sigma Securities's PFE Position: Q1 2026 in Review
Two Sigma Securities sold out of Pfizer (PFE) in Q1 2026, closing a stake of 20,529 shares — an estimated $511K sold.
Two Sigma Securities first reported a position in PFE in Q1 2015 and held it in 34 quarters. The position peaked at $19.2M in Q4 2023. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Two Sigma Securities reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
- Two Sigma Securities sold 20,529 Pfizer shares in Q1 2026, an estimated $511K.
- Two Sigma Securities first reported a position in Pfizer in Q1 2015 and held it in 34 quarters.
- Two Sigma Securities's Pfizer position peaked at $19.2M in Q4 2023.
- 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.